chronic kidney disease money
Biotech

Novo Nordisk discards $1.3B kidney drug in wake of phase 3 fail

Novo Nordisk, after mulling the implications of a phase 3 fail, has given up on a late-stage kidney drug acquired in a $1.3 billion deal.
James Waldron Nov 6, 2024 4:54am
Overcoming Barriers to Generative AI in Life Sciences RD

Overcoming Barriers to Generative AI in Life Sciences R&D

Nov 4, 2024 8:00am
graveyard halloween spooky moon

The 2024 Biotech Graveyard

Oct 31, 2024 5:00am
Discover Turbines way to build avatars true to patient biology

Discover Turbine’s way to build avatars true to patient biology

Oct 28, 2024 8:00am
money funding financing bank

Acadia makes $100M profit from $150M pediatric voucher sale

Nov 6, 2024 9:36am
Whitewater kayaking

Charles River's revenue drops amid industry restructuring work

Nov 6, 2024 3:29pm
Medtech News

FDA clears first treatment for dry AMD, with LumiThera’s Valeda

Nov 6, 2024 10:30am

CMS to pay for renal denervation from Medtronic, Recor Medical

Nov 6, 2024 4:45am

Inquis Medical draws up $40M to fund blood clot removal system

Nov 5, 2024 12:00pm

Abbott posts positive, longer-term data for its Esprit BTK stent

Nov 5, 2024 11:00am